Schedule 13D ownership disclosure

ARS Pharmaceuticals Inc

Security class unavailable · CUSIP: 82835W108

Event date: 2021-12-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-008244
Form type
SC 13D
Filer
ARS Pharmaceuticals, Inc.
CIK
CIK 1671858
Filed
Jan 27, 2022
Reporting period
Dec 13, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub